These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9202940)

  • 1. Neuromuscular blockade: is it still useful in the ICU?
    Meistelman C; Plaud B
    Eur J Anaesthesiol Suppl; 1997 May; 15():53-6. PubMed ID: 9202940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Muscle relaxants in the ICU].
    Schneider G
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2009 May; 44(5):358-64; quiz 366, 379. PubMed ID: 19440945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic impact of prolonged motor weakness complicating neuromuscular blockade in the intensive care unit.
    Rudis MI; Guslits BJ; Peterson EL; Hathaway SJ; Angus E; Beis S; Zarowitz BJ
    Crit Care Med; 1996 Oct; 24(10):1749-56. PubMed ID: 8874316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prolonged muscle weakness associated with the administration of non-depolarizing neuromuscular blocking agents in critically ill patients].
    López MP; Seiz A; Criado A
    Rev Esp Anestesiol Reanim; 2001 Oct; 48(8):375-83. PubMed ID: 11674984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A national survey on the practice patterns of anesthesiologist intensivists in the use of muscle relaxants.
    Klessig HT; Geiger HJ; Murray MJ; Coursin DB
    Crit Care Med; 1992 Sep; 20(9):1341-5. PubMed ID: 1343081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Muscular mass assessed by ultrasonography after administration of low-dose corticosteroids and muscle relaxants in critically ill hemiplegic patients.
    Moukas M; Vassiliou MP; Amygdalou A; Mandragos C; Takis F; Behrakis PK
    Clin Nutr; 2002 Aug; 21(4):297-302. PubMed ID: 12135589
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The use of muscle relaxants in the intensive care unit.
    Sharpe MD
    Can J Anaesth; 1992 Nov; 39(9):949-62. PubMed ID: 1451224
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuromuscular Blockade in the 21st Century Management of the Critically Ill Patient.
    deBacker J; Hart N; Fan E
    Chest; 2017 Mar; 151(3):697-706. PubMed ID: 27818334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Should ICU patients receive muscle relaxants?
    Coakley J
    Schweiz Med Wochenschr; 1996 Sep; 126(39):1644-8. PubMed ID: 8858758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Impact of a quality assurance program on the use of neuromuscular monitoring and reversal of muscle relaxants].
    Motamed C; Bourgain JL
    Ann Fr Anesth Reanim; 2009 Apr; 28(4):297-301. PubMed ID: 19304447
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in acetylcholine receptor number in muscle from critically ill patients receiving muscle relaxants: an investigation of the molecular mechanism of prolonged paralysis.
    Dodson BA; Kelly BJ; Braswell LM; Cohen NH
    Crit Care Med; 1995 May; 23(5):815-21. PubMed ID: 7736737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of nondepolarizing neuromuscular blocking agents in mechanically ventilated patients.
    Buck ML; Reed MD
    Clin Pharm; 1991 Jan; 10(1):32-48. PubMed ID: 1825627
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intensive-care-unit-acquired muscle weakness.
    Deem S
    Respir Care; 2006 Sep; 51(9):1042-52; discussion 1052-3. PubMed ID: 16934167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuromuscular transmission and its pharmacological blockade. Part 4: Use of relaxants in paediatric and elderly patients, in obstetrics, and in the intensive care unit.
    Booij LH
    Pharm World Sci; 1997 Feb; 19(1):45-52. PubMed ID: 9089752
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of neuromuscular monitoring to detect prolonged effect of succinylcholine or mivacurium: three case reports.
    Cassel J; Staehr-Rye AK; Nielsen CV; Gätke MR
    Acta Anaesthesiol Scand; 2014 Sep; 58(8):1040-3. PubMed ID: 24947746
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Residual neuromuscular blockade after muscle relaxants administration in neurosurgical patients].
    Anesteziol Reanimatol; 2012; (4):73-6. PubMed ID: 23082652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of peripheral nerve stimulators to monitor patients with neuromuscular blockade in the ICU.
    Kleinpell R; Bedrosian C; McCormick L; Kremer M; Bujalski L; Bronsted R
    Am J Crit Care; 1996 Nov; 5(6):449-54. PubMed ID: 8922161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tachyphylaxis to cisatracurium--case reports and literature review.
    Haddad S
    Middle East J Anaesthesiol; 2008 Jun; 19(5):1079-92. PubMed ID: 18637607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Myopathy in critically ill patients.
    Hund E
    Crit Care Med; 1999 Nov; 27(11):2544-7. PubMed ID: 10579278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute quadriplegia and loss of muscle myosin in patients treated with nondepolarizing neuromuscular blocking agents and corticosteroids: mechanisms at the cellular and molecular levels.
    Larsson L; Li X; Edström L; Eriksson LI; Zackrisson H; Argentini C; Schiaffino S
    Crit Care Med; 2000 Jan; 28(1):34-45. PubMed ID: 10667496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.